Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after helicobacter pylori infection

Helicobacter

Volumn 14, Issue 6, 2009, Pages 580-587

  Hung, Kuei Hsiang ^a   Hung, Hunt Wen ^a   Yang, Hsiao Bai ^a,b   Lu, Cheng Chan ^a   Wu, Jiunn Jong ^a   Sheu, Bor Shyang ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

H. pylori; Intestinal metaplasia; MMP 9; TIMP 1

Indexed keywords

APC PROTEIN; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GENOMIC DNA; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; OLIGONUCLEOTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HIGH RISK POPULATION; HISTOLOGY; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BIOPSY;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; MATRIX METALLOPROTEINASE 9; METAPLASIA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX CHARACTERISTICS; STOMACH; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

HELICOBACTER PYLORI;

EID: 70449458016     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00717.x     Document Type: Article

References (36)

1. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007 133 : 659 672.
2. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003 3 : 592 600.
3. Amieva MR, El-Omer EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008 134 : 306 323.
4. Höcker M, Hohenberger P. Helicobacter pylori virulence factors - one part of a big picture. Lancet 2003 362 : 1231 1233.
5. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008 135 : 91 9.
6. Sheu SM, Sheu BS, Yang HB, Li C, Chu TC, Wu JJ. Presence of iceA1 but not cagA, cagC, cagE, cagF, cagN, cagT, or orf13 genes of Helicobacter pylori is associated with more severe gastric inflammation in Taiwanese. J Formos Med Assoc 2002 101 : 18 23.
7. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 2003 52 : 927 932.
8. Sheu SM, Hung KH, Sheu BS, Yang HB, Wu JJ. Association of amino acid substitutions in the i-region of the vacA gene of Helicobacter pylori with gastric diseases in Taiwan. J Clin Microbiol 2009 47 : 249 251.
9. Bergman M, Del Prete G, van Kooyk Y, Appelmelk B. Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol 2006 4 : 151 159.
10. Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007 133 : 288 308.
11. Wang D, Mann JR, DuBois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 2005 128 : 1445 1461.
12. Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005 23 : 2840 2855.
13. Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005 142 : 12 20.
14. Kundu P, Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 2006 281 : 34651 34662.
15. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 2 : 161 174.
16. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20 : 1161 1181.
17. Yang HB, Cheng HC, Sheu BS, Hung KH, Liou MF, Wu JJ. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther 2007 25 : 455 461.
18. Lu CC, Sheu BS, Chen TW, et al. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am J Gastroenterol 2005 100 : 1274 1282.
19. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002 94 : 1680 1687.
20. Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003 188 : 272 281.
21. Leung WK, Chan MC, To KF, et al. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 2006 101 : 714 720.
22. Wu MS, Chen LT, Shun CT, et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 2004 110 : 695 700.
23. Kato I, van Doorn LJ, Canzian F, et al. Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer 2006 119 : 1666 1671.
24. Kamangar F, Cheng C, Abnet CC, Rabkin CS. Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006 15 : 1920 1928. (Pubitemid 44664269)
25. Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005 29 : 141 152.
26. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003 104 : 617 623.
27. Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 2003 9 : 5245 5251.
28. Liu F, Pan K, Zhang X, et al. Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 2006 130 : 1975 1984.
29. Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007 26 : 4617 4626.
30. Hung KH, Wu JJ, Yang HB, Su LJ, Sheu BS. Host Wnt/β-catenin pathway triggered by H. pylori correlates to the regression of gastric intestinal metaplasia after H. pylori eradication. J Med Microbiol 2009 58 : 567 576.
31. Ogasawara N, Tsukamoto T, Mizoshita T, et al. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 2006 49 : 612 621.
32. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007 13 : 2960 2966.
33. Kubben FJ, Sier CF, Meijer MJ, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 2006 95 : 744 751.
34. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991 266 : 13070 13075.
35. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005 128 : 1567 1578.
36. Lochhead P, El-Omar EM. Gastric cancer. Br Med Bull 2008 85 : 87 100.